ARCHIVES

Health Canada Suspends Avastin Approval; CMS Has Taken No Action After FDA Decision

This article is from The Cancer Letter archive.

Vol. 37 No. 44 | December 2, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

April 26, 1996

In Brief: UICC Publishes International directory Of Cancer Centers; HSAs Still Worry NCI

January 7, 1977

Guest Editorial: Anil Potti Hires “Online Reputation Managers” As Journals Retract His Biomarker Research

April 15, 2011

Funding Opportunities

December 6, 2002

Consortium Centers Pose Problems To Some, But claim They “Coincide With Congress’ Intent”

December 9, 1977

DCT To Announce Three New CRAGs

November 12, 1976